Download A phase 1/2 study of an adjuvanted varicella-zoster virus - E

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Transcript
Why was this
study conducted?
Edward A. Stadtmauer et al. Blood 2014;124:2921-2929
HCTx recipients are susceptible to early VZV infection
Studies have demonstrated that live attenuated VZV vaccines are
immunogenic in these pts – safety?
Is an adjuvanted gE vaccine immunogenic and safe enough to use
in the early postHCTx period?
NCT00920218 (clinicaltrials.gov)